Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taiwan Global Biofund (TGB) is a venture capital firm based in Taipei, Taiwan, specializing in the biotechnology and healthcare sectors. Established in 2005 and managed by YFY Biotech Management Company, the fund was created to support the growth of innovative biotech companies through capital investment and strategic guidance. TGB provides integrated services including technology assessment, human resources, and business development to its portfolio companies. Its investment strategy has historically targeted various stages of development, from seed and early-stage to growth phases, with a particular focus on the Taiwanese biotech ecosystem. Notable investments include TaiGen Biotechnology, Somnics, and iXensor. The fund is part of the Yuen Foong Yu (YFY) Group's broader commitment to advancing the life sciences industry in the Asia-Pacific region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Taiwan Global Biofund.